Market Trends of Global Anal Fistula Treatment Industry
This section covers the major market trends shaping the Anal Fistula Treatment Market according to our research experts:
Surgical Segment is Expected to Dominate the Anal Fistula Treatment Market During the Forecast Period
The surgical treatment for an anal fistula is found to be associated with low recurrence rates, minimal incontinence, and good quality of life. The best option is found to depend on the position of the fistula and whether it is a single channel or branches off in different directions. Surgical procedures include fistulotomy, bioprosthetic plugs, advancement flap procedures, seton techniques, and new techniques such as LIFT and FiLaC therapy. The most common type of surgery for anal fistulas is a fistulotomy.
The surgical segment is found to dominate the anal fistula treatment market due to the increasing incidences of fistula-induced infections, and the rise in demand for safe and effective treatment. For instance, as per the article published in 2021 under the title 'Anal Fistula: Contemporary View of Complex Problem', surgery like fistulotomy has a success rate of more than 90%. As per the same source, medical therapy in combination with surgical solutions is anticipated to significantly reduce the severity of the disease and even hope to eradicate it. Since patients having anal fistula are suggested to go for surgeries to eradicate the problem, the adoption of the surgery segment is likely to increase over the forecast.
Moreover, as per the 2021 update from Cancer.Net, an anal fistula is likely to increase the risk of developing anal/rectal cancer. As per the article published in 2022 under the title 'Anal fistula metastasis of rectal cancer after neoadjuvant therapy: a case report', the study showed the importance of anorectal physical examination before, during, or after neoadjuvant therapy for rectal cancer, because implantation metastasis to the anal fistula is likely to occur any time during treatment. Since the population with the anal fistula along with the risk of rectal cancer is likely to adopt the surgical treatment, the market is expected to grow over the forecast period.
North America is Expected to Dominate the Anal Fistula Treatment Market During the Forecast Period
North America is likely to be dominating the anal fistula market due to a large patient population with inflammatory bowel diseases, early adoption of new technologies, and high healthcare expenditure by the public and private sectors in the studied region. For instance, as per the Mayo Clinic 2022 report, Mayo Clinic surgeons have extensive experience with anal fistulas, treating more than 1,000 people every year in America.
Furthermore, the advancements in the field of the anal fistula market in the studied region are likely to boost the market growth over the forecast period. For instance, in 2021, California-based Ossium Health collaborated with a researcher from Cleveland Clinic for conducting a clinical trial under the title 'Study of Ossium Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in the Setting of Crohn's Disease', the goal of the study is to investigate the safety and feasibility of using Ossium vertebral Bone Marrow-Derived Mesenchymal Stem Cells (vBM-MSC) to treat people with an ileal pouch-anal anastomosis (IPAA) who develop a fistula in the setting of Crohn's disease of the pouch. Furthermore, in 2020 the same research institution conducted a clinical trial under the title ' Study of Mesenchymal Stem Cells for the Treatment of Ileal Pouch Fistula's in Participants With Crohn's Disease (IPAAF)', the purpose of this study is to evaluate the safety and efficacy of using allogeneic bone marrow-derived mesenchymal stem cells to treat people who have a peri-pouch fistula related to a clinical diagnosis of Crohn's disease of the pouch. Hence, increased research and development in the field of anal fistula are likely to boost market growth over the forecast period.
Furthermore, the presence of competitors, awareness regarding GI diseases, product launches, and acquisitions boosts the market growth in the studied region. For instance, Cross Valley Health & Medicine celebrates National Colorectal Cancer Awareness Month each March. Each year, healthcare providers take this month to provide their patients with extra education about diseases of the colon and rectum. People become more aware of diseases in the rectum as a result of such awareness initiatives by the government and this is likely to promote market growth over the forecast period.
